npj Vaccines
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.2 | Q1 | 86.3% | 2.282 | Q1 | 96.3% |
| 2024 | 6.5 | Q1 | 84.6% | 2.236 | Q1 | 96.2% |
| 2023 | 6.9 | Q1 | 88.1% | 2.127 | Q1 | 96.0% |
| 2022 | 9.2 | Q1 | 89.2% | 3.197 | Q1 | 98.2% |
| 2021 | 9.4 | Q1 | 87.8% | 2.953 | Q1 | 98.0% |
| 2020 | — | — | 2.691 | Q1 | 97.4% | |
| 2019 | — | — | 2.465 | Q1 | 96.9% | |
| 2018 | — | — | 2.527 | Q1 | 96.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2059-0105
country
GBcoverage
2016-2026